2020-003640-88: A long-term safety surveillance study in participants previously treated with 177Lu-IPN01072 |
|
|
| Not yet recruiting | 1/2 | 38 | Europe | 177Lu-satoreotide tetraxetan, 177Lu-SSO110, 177Lu-IPN01072,177Lu-OPS201, Solution for injection | Ariceum Therapeutics GmbH, Ariceum Therapeutics GmbH | Neuroendocrine tumors (NETs), Neuroendocrine tumors (NETs), neoplasms that arise from cells of the endocrine (hormonal) and nervous systems., Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Investigative Techniques [E05] | | | | |